ArticleJournal of imaging informatics in medicine2026
Interpretable MRI Subregional Radiomics-Deep Learning Model for Preoperative Lymphovascular Invasion Prediction in Rectal Cancer: A Dual-Center Study.
Article in Journal of imaging informatics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Deep learning model based on MRI-derived microvascular network simulation parameters for noninvasive assessment of lymphovascular invasion in rectal cancer patients.Journal of gastrointestinal oncology · 2026Article
- MRI-Based Morphological Features as Predictors of Clinical Outcomes in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy: Insights from a Single-Institution Experience.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Develop a fusion model based on explainable machine learning, combining multiparametric MRI subregional radiomics and deep learning, to preoperatively predict the lymphovascular invasion status in rectal cancer. We collected data from RC patients with histopathological confirmation from two medical centers, with 301 patients used as a training set and 75 patients as an external validation set. Using K-means clustering techniques, we meticulously divided the tumor areas into multiple subregions and extracted crucial radiomic features from them. Additionally, we employed an advanced Vision Transformer (ViT) deep learning model to extract features. These features were integrated to construct the SubViT model. To better understand the decision-making process of the model, we used the Shapley Additive Properties (SHAP) tool to evaluate the model's interpretability. Finally, we comprehensively assessed the performance of the SubViT model through receiver operating characteristic (ROC) curves, decision curve analysis (DCA), and the Delong test, comparing it with other models. In this study, the SubViT model demonstrated outstanding predictive performance in the training set, achieving an area under the curve (AUC) of 0.934 (95% confidence interval: 0.9074 to 0.9603). It also performed well in the external validation set, with an AUC of 0.884 (95% confidence interval: 0.8055 to 0.9616), outperforming both subregion radiomics and imaging-based models. Furthermore, decision curve analysis (DCA) indicated that the SubViT model provides higher clinical utility compared to other models. As an advanced composite model, the SubViT model demonstrated its efficiency in the non-invasive assessment of local vascular invasion (LVI) in rectal cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.